Analyst EPS estimates for Standard BioTools Inc (LAB) stock

In other words, the price has increased by $0.0000 from its previous closing price. On the day, 1912600 shares were traded.

Ratios:

Our goal is to gain a better understanding of LAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.21.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on July 12, 2023, initiated with a Overweight rating and assigned the stock a target price of $4.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 when Casdin Eli bought 800,000 shares for $2.29 per share. The transaction valued at 1,835,920 led to the insider holds 1,200,000 shares of the business.

Casdin Partners Master Fund, L bought 800,000 shares of LAB for $1,835,920 on May 19. The Director now owns 1,200,000 shares after completing the transaction at $2.29 per share. On May 19, another insider, Black Jeffrey G., who serves as the SVP & Chief Financial Officer of the company, bought 42,492 shares for $2.29 each. As a result, the insider paid 97,213 and bolstered with 85,984 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 748.50M and an Enterprise Value of 731.82M. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.04. Its current Enterprise Value per Revenue stands at 6.88 whereas that against EBITDA is -13.44.

Stock Price History:

Over the past 52 weeks, LAB has reached a high of $3.16, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 2.2836, while the 200-Day Moving Average is calculated to be 2.3365.

Shares Statistics:

The stock has traded on average 1.57M shares per day over the past 3-months and 1.69M shares per day over the last 10 days, according to various share statistics. A total of 290.12M shares are outstanding, with a floating share count of 280.45M. Insiders hold about 3.33% of the company’s shares, while institutions hold 31.68% stake in the company. Shares short for LAB as of Feb 15, 2024 were 8.06M with a Short Ratio of 5.12, compared to 7.67M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.78% and a Short% of Float of 2.96%.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.01 and -$0.01 for the fiscal current year, implying an average EPS of -$0.01. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.

Most Popular

[the_ad id="945"]